argenx SE Investor Day Presentation Deck slide image

argenx SE Investor Day Presentation Deck

ARGX-117 Phase 1 Data | New Biology Insights for Multifocal Motor Neuropathy Olivier Van de Steen, Medical Director Inge Van de Walle, Principal Scientist argenx
View entire presentation